Lee, Danner & Bass’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,000
| Closed | -$5K | – | 751 |
|
|
2024
Q3 | $5K | Hold |
50,000
| – | – | ﹤0.01% | 220 |
|
|
2024
Q2 | $6K | Buy |
+50,000
| New | +$6K | ﹤0.01% | 211 |
|
|
2023
Q4 | $5K | Hold |
50,000
| – | – | ﹤0.01% | 205 |
|
|
2023
Q3 | $4K | Hold |
50,000
| – | – | ﹤0.01% | 199 |
|
|
2023
Q2 | $6K | Hold |
50,000
| – | – | ﹤0.01% | 204 |
|
|
2023
Q1 | $8K | Hold |
50,000
| – | – | ﹤0.01% | 196 |
|
|
2022
Q4 | $5K | Hold |
50,000
| – | – | ﹤0.01% | 196 |
|
|
2022
Q3 | $2K | Hold |
50,000
| – | – | ﹤0.01% | 195 |
|
|
2022
Q2 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q1 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 204 |
|
|
2021
Q4 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 199 |
|
|
2021
Q3 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 198 |
|
|
2021
Q2 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 204 |
|
|
2021
Q1 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 192 |
|
|
2020
Q4 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 185 |
|
|
2020
Q3 | $4K | Hold |
50,000
| – | – | ﹤0.01% | 178 |
|
|
2020
Q2 | $2K | Buy |
+50,000
| New | +$2K | ﹤0.01% | 179 |
|